XENE
Xenon Pharmaceuticals Inc. · Healthcare
Chief Medical Officer Christopher John Kenney sold $426K of Xenon Pharmaceuticals Inc.
Sold$425,829
$60.25Price
7,068Shares
−100%Stake
What XENE did after the filing
- The stock from Tue, Sep 1 open, $60.48
- −43.9%
- S&P 500, same days
- +1.0%
Measured over 30 trading days, to the Oct 14 close.
Traded Fri, Aug 28. Filed Mon, Aug 31, 9:59 PM ET, after the close. Returns use the Sep 1 open and the Oct 14 close. Not investment advice.